Published in Peptides on March 01, 2001
Peptide YY is critical for acylethanolamine receptor Gpr119-induced activation of gastrointestinal mucosal responses. Cell Metab (2010) 1.71
The melanocortin-4 receptor is expressed in enteroendocrine L cells and regulates the release of peptide YY and glucagon-like peptide 1 in vivo. Cell Metab (2014) 1.60
Neuropeptide Y, Y1, Y2 and Y4 receptors mediate Y agonist responses in isolated human colon mucosa. Br J Pharmacol (2002) 1.09
Functional consequences of neuropeptide Y Y 2 receptor knockout and Y2 antagonism in mouse and human colonic tissues. Br J Pharmacol (2003) 0.98
The regulation of veratridine-stimulated electrogenic ion transport in mouse colon by neuropeptide Y (NPY), Y1 and Y2 receptors. Br J Pharmacol (2005) 0.89
Endogenous peptide YY and neuropeptide Y inhibit colonic ion transport, contractility and transit differentially via Y₁ and Y₂ receptors. Br J Pharmacol (2011) 0.89
The ability of neuropeptide Y to mediate responses in the murine cutaneous microvasculature: an analysis of the contribution of Y1 and Y2 receptors. Br J Pharmacol (2003) 0.82
Endogenous PYY and NPY mediate tonic Y1- and Y2-mediated absorption in human and mouse colon. Nutrition (2008) 0.82
Selective increase of dark phase water intake in neuropeptide-Y Y2 and Y4 receptor knockout mice. Behav Brain Res (2005) 0.80
Endogenous PYY and GLP-1 mediate l-glutamine responses in intestinal mucosa. Br J Pharmacol (2013) 0.80
Gastrointestinal hormonal responses on GPR119 activation in lean and diseased rodent models of type 2 diabetes. Int J Obes (Lond) (2014) 0.79
L-arginine promotes gut hormone release and reduces food intake in rodents. Diabetes Obes Metab (2016) 0.78
Gastrointestinal neuroendocrine peptides/amines in inflammatory bowel disease. World J Gastroenterol (2017) 0.75
A neural basis for general intelligence. Science (2000) 4.49
XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. Pharmacol Rev (1998) 2.58
Brain and brain tumor uptake of L-3-[123I]iodo-alpha-methyl tyrosine: competition with natural L-amino acids. J Nucl Med (1991) 2.07
Role of the premotor cortex in recovery from middle cerebral artery infarction. Arch Neurol (1998) 1.94
Functional anatomy of intrinsic alertness: evidence for a fronto-parietal-thalamic-brainstem network in the right hemisphere. Neuropsychologia (1999) 1.76
Striatal glucose consumption in chorea-free subjects at risk of Huntington's disease. J Neurol (1993) 1.71
Regional distribution of Y-receptor subtype mRNAs in rat brain. Eur J Neurosci (1999) 1.66
Y-receptor subtypes--how many more? Trends Neurosci (1997) 1.55
Fully-3D PET image reconstruction using scanner-independent, adaptive projection data and highly rotation-symmetric voxel assemblies. IEEE Trans Med Imaging (2011) 1.54
The comparison of 2-18F-2-deoxyglucose and 15-(ortho-123I-phenyl)-pentadecanoic acid uptake in persisting defects on thallium-201 tomography in myocardial infarction. J Nucl Med (1991) 1.51
Cortical and subcortical glucose consumption measured by PET in patients with Huntington's disease. Brain (1990) 1.44
Noninvasive assessment of regional cardiac adenosine using positron emission tomography. J Nucl Med (1992) 1.41
The neural circuitry involved in the reading of German words and pseudowords: A PET study. J Cogn Neurosci (1999) 1.35
The influence of plasma glucose levels on fluorine-18-fluorodeoxyglucose uptake in bronchial carcinomas. J Nucl Med (1993) 1.35
Frontal lobe function in amyotrophic lateral sclerosis: a neuropsychologic and positron emission tomography study. Acta Neurol Scand (1992) 1.29
History of tuberculosis. Respiration (1998) 1.24
Optimal scan time for fluorine-18 fluorodeoxyglucose positron emission tomography in breast cancer. Eur J Nucl Med (1999) 1.21
Expectation maximization reconstruction of positron emission tomography images using anatomical magnetic resonance information. IEEE Trans Med Imaging (1997) 1.20
Expression of the neuropeptide Y Y1 receptor in the CNS of rat and of wild-type and Y1 receptor knock-out mice. Focus on immunohistochemical localization. Neuroscience (2002) 1.18
[New theoretical values in exploration of the respiratory function of the lung]. Bull Physiopathol Respir (Nancy) (1972) 1.17
Peptide YY ablation in mice leads to the development of hyperinsulinaemia and obesity. Diabetologia (2006) 1.16
Distribution and utilization of 15N in cowpeas injected into the stem under influence of water deficit. Isotopes Environ Health Stud (2000) 1.16
The role of diaschisis in stroke recovery. Stroke (1999) 1.14
[Infection experiments with the cotton rat filaria Litomosoides carinii in Mastomys natalensis (Smith, 1834)]. Z Parasitenkd (1968) 1.13
Episodic retrieval activates the precuneus irrespective of the imagery content of word pair associates. A PET study. Brain (1999) 1.12
Site-directed mutagenesis of recombinant human beta 2-glycoprotein I identifies a cluster of lysine residues that are critical for phospholipid binding and anti-cardiolipin antibody activity. J Immunol (1996) 1.12
Performance characteristics of an eight-ring whole body PET scanner. J Comput Assist Tomogr (1990) 1.10
Candidaemia and bacterial infections in patients with lung disease. Lancet (1976) 1.09
Coeliac disease: in vivo toxicity of the putative immunodominant epitope. Gut (2003) 1.08
Animal research. Reliability of protocol reviews for animal research. Science (2001) 1.08
A neural correlate of syntactic encoding during speech production. Proc Natl Acad Sci U S A (2001) 1.07
A human ubiquitin-conjugating enzyme homologous to yeast UBC8. J Biol Chem (1994) 1.07
Neural correlates of religious experience. Eur J Neurosci (2001) 1.05
PET imaging with yttrium-86: comparison of phantom measurements acquired with different PET scanners before and after applying background subtraction. Eur J Nucl Med Mol Imaging (2003) 1.03
The effect of MR surface coils on PET quantification in whole-body PET/MR: results from a pseudo-PET/MR phantom study. Med Phys (2011) 1.01
GPR56, a novel secretin-like human G-protein-coupled receptor gene. Genomics (1999) 1.01
Impaired thrombin generation in beta 2-glycoprotein I null mice. J Biol Chem (2001) 1.00
Investigation of the putative immunodominant T cell epitopes in coeliac disease. Gut (2003) 0.99
A novel neuropeptide Y analog, N-acetyl [Leu28,Leu31]neuropeptide Y-(24-36), with functional specificity for the presynaptic (Y2) receptor. Eur J Pharmacol (1994) 0.98
The design of an animal PET: flexible geometry for achieving optimal spatial resolution or high sensitivity. IEEE Trans Med Imaging (1997) 0.97
Syntactic processing in left prefrontal cortex is independent of lexical meaning. Neuroimage (2001) 0.97
Influence of age on pulmonary haemodynamics at rest and during supine exercise. Clin Sci (Lond) (1983) 0.96
Increased novelty-induced motor activity and reduced depression-like behavior in neuropeptide Y (NPY)-Y4 receptor knockout mice. Neuroscience (2008) 0.95
Peripheral neuropeptide Y Y1 receptors regulate lipid oxidation and fat accretion. Int J Obes (Lond) (2009) 0.95
The role of ventral medial wall motor areas in bimanual co-ordination. A combined lesion and activation study. Brain (1999) 0.94
Large-scale plasticity of the human motor cortex. Neuroreport (1995) 0.94
Precentral glioma location determines the displacement of cortical hand representation. Neurosurgery (1998) 0.94
Conscious and subconscious sensorimotor synchronization--prefrontal cortex and the influence of awareness. Neuroimage (2002) 0.93
Y-receptor-like genes GPR72 and GPR73: molecular cloning, genomic organisation and assignment to human chromosome 11q21.1 and 2p14 and mouse chromosome 9 and 6. Biochim Biophys Acta (2000) 0.92
Isolation of a cDNA clone for human NAD+: protein ADP-ribosyltransferase. Eur J Cell Biol (1987) 0.92
3-[123I]iodo-alpha-methyltyrosine and [methyl-11C]-L-methionine uptake in cerebral gliomas: a comparative study using SPECT and PET. J Nucl Med (1997) 0.92
Calcitonin gene-related peptide receptors in human gastrointestinal epithelia. Br J Pharmacol (1994) 0.91
Neurolept analgesia for bronchoscopic examinations. Chest (1975) 0.89
Comparison of somatosensory evoked potentials with striatal glucose consumption measured by positron emission tomography in the early diagnosis of Huntington's disease. Mov Disord (1993) 0.89
Chemotherapeutic studies on Litomosoides carinii infection of Mastomys natalensis. 1. The filaricidal action of 2,6-bis-benzimidazoles. Bull World Health Organ (1971) 0.89
Functional characterization of receptors with affinity for PYY, NPY, [Leu31,Pro34]NPY and PP in a human colonic epithelial cell line. Br J Pharmacol (1995) 0.89
Kinetics of 14(R,S)-fluorine-18-fluoro-6-thia-heptadecanoic acid in normal human hearts at rest, during exercise and after dipyridamole injection. J Nucl Med (1994) 0.89
Tomographic studies of rCBF with [99mTc]-HM-PAO SPECT in patients with brain tumors: comparison with C15O2 continuous inhalation technique and PET. J Cereb Blood Flow Metab (1988) 0.89
Endogenous peptide YY and neuropeptide Y inhibit colonic ion transport, contractility and transit differentially via Y₁ and Y₂ receptors. Br J Pharmacol (2011) 0.89
Neuropeptide Y and the nonpeptide antagonist BIBP 3226 share an overlapping binding site at the human Y1 receptor. Mol Pharmacol (1996) 0.88
The peptide YY-preferring receptor mediating inhibition of small intestinal secretion is a peripheral Y(2) receptor: pharmacological evidence and molecular cloning. Mol Pharmacol (2001) 0.88
Reduced anxiety-like and depression-related behavior in neuropeptide Y Y4 receptor knockout mice. Genes Brain Behav (2008) 0.88
Cerebral glucose metabolism in type 1 diabetic patients. Diabet Med (1994) 0.88
Transcriptional regulation and autoregulation of the human gene for ADP-ribosyltransferase. Mol Cell Biochem (1994) 0.87
Animal rights and wrongs. Science (1993) 0.87
Endogenous neuropeptide Y depresses the afferent signaling of gastric acid challenge to the mouse brainstem via neuropeptide Y type Y2 and Y4 receptors. Neuroscience (2005) 0.87
Purification and characterization of NAD+:ADP-ribosyltransferase (polymerizing) from Dictyostelium discoideum. Biochem J (1993) 0.86
Synergistic effects of genetic beta cell dysfunction and maternal glucose intolerance on offspring metabolic phenotype in mice. Diabetologia (2010) 0.86
Interdependence of regional and global cerebral blood flow during visual stimulation: an O-15-butanol positron emission tomography study. J Cereb Blood Flow Metab (2001) 0.86
Chemotherapeutic studies on Litomosoides carinii infection of Mastomys natalensis. 3. The activity of drugs against adult parasites. Bull World Health Organ (1971) 0.86
Synergistic interaction of Y1-neuropeptide Y and alpha 1b-adrenergic receptors in the regulation of phospholipase C, protein kinase C, and arachidonic acid production. J Biol Chem (1995) 0.86
[Evaluation of lung operability from the standpoint of hemodynamics in the pulmonary circulation]. Pneumonologie (1971) 0.85
Brain systems engaged in encoding and retrieval of word-pair associates independent of their imagery content or presentation modalities. Neuropsychologia (2002) 0.85
Molecular cloning and characterisation of GPR74 a novel G-protein coupled receptor closest related to the Y-receptor family. Brain Res Mol Brain Res (2000) 0.85
Abnormal postprandial PYY response in insulin sensitive nondiabetic subjects with a strong family history of type 2 diabetes. Int J Obes (Lond) (2008) 0.84
[New normal values for the pulmonary function test with whole body plethysmography]. Dtsch Med Wochenschr (1969) 0.84
NPY controls fear conditioning and fear extinction by combined action on Y₁ and Y₂ receptors. Br J Pharmacol (2012) 0.84
Human nuclear NAD+ ADP-ribosyltransferase(polymerizing): organization of the gene. DNA (1989) 0.84
Visual hallucinations in recovery from cortical blindness: imaging correlates. Arch Neurol (2000) 0.84
A role for neuropeptide Y in the gender-specific gastrointestinal, corticosterone and feeding responses to stress. Br J Pharmacol (2012) 0.83
Roles of peptides and other substances in cotransmission from vascular autonomic and sensory neurons. Can J Physiol Pharmacol (1995) 0.83
Relationship of a novel polymorphic marker near the human obese (OB) gene to fat mass in healthy women. Obes Res (1997) 0.83
Gene duplication of the human peptide YY gene (PYY) generated the pancreatic polypeptide gene (PPY) on chromosome 17q21.1. Genomics (1995) 0.83
Inhibition of cyclic AMP-dependent chloride secretion by PP receptors and alpha 2-adrenoceptors in a human colonic epithelial cell line. Naunyn Schmiedebergs Arch Pharmacol (1997) 0.83
Expression of the human neuropeptide tyrosine Y1 receptor. Proc Natl Acad Sci U S A (1993) 0.83
Quantification of glucose transport and phosphorylation in human skeletal muscle using FDG PET. J Nucl Med (1999) 0.83
Constitutive neuropeptide Y Y(4) receptor expression in human colonic adenocarcinoma cell lines. Br J Pharmacol (2001) 0.83
Multiple promoters regulate tissue-specific expression of the human NPY-Y1 receptor gene. J Biol Chem (1995) 0.83
Impact of the lower energy threshold on the NEMA NU2-2001 count-rate performance of a LSO based PET-CT scanner. Nuklearmedizin (2008) 0.83
Comparison of Y-receptor subtype expression in the rat hippocampus. Regul Pept (1998) 0.83
Individual somatotopy of primary sensorimotor cortex revealed by intermodal matching of MEG, PET, and MRI. Brain Topogr (1992) 0.83
Stimulation of chloride secretion and adenylate cyclase secretion in human colonic derived cell lines by calcitonin gene-related peptide. Biochem Soc Trans (1993) 0.83
Glucose transport and utilization in the human brain: model using carbon-11 methylglucose and positron emission tomography. J Nucl Med (1986) 0.83
Genomic organization and localization of the gene encoding human preprogalanin. Genomics (1993) 0.82
Uptake kinetics of the somatostatin receptor ligand [86Y]DOTA-DPhe1- Tyr3-octreotide ([86Y]SMT487) using positron emission tomography in non-human primates and calculation of radiation doses of the 90Y-labelled analogue. Eur J Nucl Med (1999) 0.82
Novel neuropeptide Y1 and Y5 receptor gene variants: associations with serum triglyceride and high-density lipoprotein cholesterol levels. Clin Genet (2002) 0.82
NPY signalling pathway in bone homeostasis: Y1 receptor as a potential drug target. Curr Drug Targets (2009) 0.82
Novel polymorphisms in the neuropeptide-Y Y5 receptor associated with obesity in Pima Indians. Int J Obes Relat Metab Disord (2000) 0.82
[Precipitating antibodies in the serum of Mastomys natalensis in the course of Litomosoides carinii infection]. Z Parasitenkd (1970) 0.82
Inhibitory effects of central neuropeptide Y on the somatotropic and gonadotropic axes in male rats are independent of adrenal hormones. Peptides (2001) 0.82